Literature DB >> 10694490

Translocation of HSP27 to sarcomere induced by ischemic preconditioning in isolated rat hearts.

K Sakamoto1, T Urushidani, T Nagao.   

Abstract

We investigated the role of the 27-kDa heat shock protein (HSP27) in cardiac protection using Langendorff-perfused rat hearts. After preconditioning (a single episode of 5 min global ischemia followed by 5 min of reperfusion), HSP27 redistributed from the cytosol to the sarcomere and recovery of the contractile function, after 40 min of global ischemia and 50 min of reperfusion, was significantly enhanced. Both SB203580, a p38 MAP kinase inhibitor, and bisindolylmaleimide I, a protein kinase C inhibitor, prevented the effects of preconditioning. Both 2-chloro-N(6)-cyclopentyladenosine (adenosine A1 agonist) and anisomycin (activator of p38 MAP kinase and c-jun N-terminal kinase) mimicked preconditioning. These results suggest that activation of protein kinase C followed by activation of p38 MAP kinase elicits translocation of HSP27 to the sarcomere, a process which may be involved in the cardioprotective mechanism afforded by ischemic preconditioning in rat heart. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694490     DOI: 10.1006/bbrc.2000.2233

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Hepatocyte cytoskeleton during ischemia and reperfusion--influence of ANP-mediated p38 MAPK activation.

Authors:  Melanie Keller; Alexander L Gerbes; Stefanie Kulhanek-Heinze; Tobias Gerwig; Uwe Grutzner; Nico van Rooijen; Angelika M Vollmar; Alexandra K Kiemer
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

2.  Mechanisms of xenon- and isoflurane-induced preconditioning - a potential link to the cytoskeleton via the MAPKAPK-2/HSP27 pathway.

Authors:  Nina C Weber; Octavian Toma; Jessica I Wolter; Nicole M Wirthle; Wolfgang Schlack; Benedikt Preckel
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

3.  Distribution, phosphorylation, and activities of Hsp25 in heat-stressed H9c2 myoblasts: a functional link to cytoprotection.

Authors:  Anton L Bryantsev; Svetlana A Loktionova; Olga P Ilyinskaya; Eduard M Tararak; Harm H Kampinga; Alexander E Kabakov
Journal:  Cell Stress Chaperones       Date:  2002-04       Impact factor: 3.667

4.  p38 Mitogen-activated protein kinase mediates a negative inotropic effect in cardiac myocytes.

Authors:  Pu Liao; Shi-Qiang Wang; Su Wang; Ming Zheng; Meizi Zheng; Sheng-Jun Zhang; Heping Cheng; Yibin Wang; Rui-Ping Xiao
Journal:  Circ Res       Date:  2002-02-08       Impact factor: 17.367

5.  Hsp27 is persistently expressed in zebrafish skeletal and cardiac muscle tissues but dispensable for their morphogenesis.

Authors:  Nathan R Tucker; Alexey Ustyugov; Anton L Bryantsev; Michael E Konkel; Eric A Shelden
Journal:  Cell Stress Chaperones       Date:  2009-02-24       Impact factor: 3.667

Review 6.  Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology.

Authors:  Tána Ravingerová; Miroslav Barancík; Monika Strnisková
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

7.  Cardiac expression of Brn-3a and Brn-3b POU transcription factors and regulation of Hsp27 gene expression.

Authors:  Saleha R Farooqui-Kabir; James K J Diss; Deborah Henderson; Michael S Marber; David S Latchman; Vishwanie Budhram-Mahadeo; Richard J Heads
Journal:  Cell Stress Chaperones       Date:  2008-03-27       Impact factor: 3.667

Review 8.  Cardiovascular proteomics: past, present, and future.

Authors:  Melanie Y White; Jennifer E Van Eyk
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

9.  Hsp27 associates with the titin filament system in heat-shocked zebrafish cardiomyocytes.

Authors:  Nathan R Tucker; Eric A Shelden
Journal:  Exp Cell Res       Date:  2009-07-04       Impact factor: 3.905

Review 10.  Membranes: a meeting point for lipids, proteins and therapies.

Authors:  Pablo V Escribá; José M González-Ros; Félix M Goñi; Paavo K J Kinnunen; Lászlo Vigh; Lissete Sánchez-Magraner; Asia M Fernández; Xavier Busquets; Ibolya Horváth; Gwendolyn Barceló-Coblijn
Journal:  J Cell Mol Med       Date:  2008-02-08       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.